- Report
- January 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- October 2023
- 150 Pages
Global
From €4654EUR$4,850USD£4,008GBP
- Report
- November 2023
- 78 Pages
Global
From €2351EUR$2,450USD£2,025GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Report
- June 2023
- 155 Pages
Global
From €2399EUR$2,500USD£2,066GBP
- Report
- November 2023
- 151 Pages
North America
From €1439EUR$1,500USD£1,240GBP
- Report
- May 2024
- 412 Pages
Global
From €6712EUR$6,995USD£5,781GBP
- Report
- June 2023
- 600 Pages
Global
From €3454EUR$3,600USD£2,975GBP
- Report
- May 2024
- 189 Pages
Global
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- March 2024
- 182 Pages
Global
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- February 2024
- 150 Pages
Global
From €5709EUR$5,950USD£4,917GBP
- Report
- February 2024
- 110 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- October 2023
- 175 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- October 2023
- 183 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1199EUR$1,250USD£1,033GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Report
- October 2023
- 172 Pages
Global
From €4701EUR$4,900USD£4,049GBP
The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more